Personalized Medicine Drug Target Extracellular Arthritis (Clinical Trials) Equipment
1 equipment items found
-
Manufactured by Augurex Life Sciences Corp.based in CANADA
In the development of RA and other inflammatory types of arthritis, multiple factors contribute to disease processes to varying degrees in different patients. 14-3-3η is recognized as a new factor within this process and represents a rationale drug target for personalized medicine alongside its 14-3-3η ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you